Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 5, 2019 | Supplemental Material
Journal Article Open

Directed Evolution of a Cytochrome P450 Carbene Transferase for Selective Functionalization of Cyclic Compounds

Abstract

Transfers of carbene moieties to heterocycles or cyclic alkenes to obtain C(sp^2)–H alkylation or cyclopropane products are valuable transformations for synthesis of pharmacophores and chemical building blocks. Through their readily tunable active-site geometries, hemoprotein "carbene transferases" could provide an alternative to traditional transition metal catalysts by enabling heterocycle functionalizations with high chemo-, regio-, and stereocontrol. However, carbene transferases accepting heterocyclic substrates are scarce; the few enzymes capable of heterocycle or cyclic internal alkene functionalization described to date are characterized by low turnovers or depend on artificially introduced, costly iridium–porphyrin cofactors. We addressed this challenge by evolving a cytochrome P450 for highly efficient carbene transfer to indoles, pyrroles, and cyclic alkenes. We first developed a spectrophotometric high-throughput screening assay based on 1-methylindole C3-alkylation that enabled rapid analysis of thousands of P450 variants and comprehensive directed evolution via random and targeted mutagenesis. This effort yielded a P450 variant with 11 amino acid substitutions and a large deletion of the non-catalytic P450 reductase domain, which chemoselectively C_3-alkylates indoles with up to 470 turnovers per minute and 18 000 total turnovers. We subsequently used this optimized alkylation variant for parallel evolution toward more challenging heterocycle carbene functionalizations, including C_2/C_3 regioselective pyrrole alkylation, enantioselective indole alkylation with ethyl 2-diazopropanoate, and cyclic internal alkene cyclopropanation. The resulting set of efficient biocatalysts showcases the tunability of hemoproteins for highly selective functionalization of cyclic targets and the power of directed evolution to enhance the scope of new-to-nature enzyme catalysts.

Additional Information

© 2019 American Chemical Society. Received: March 17, 2019; Published: May 9, 2019. This work was supported by a grant from the National Science Foundation, Division of Molecular and Cellular Biosciences, to F.H.A. (NSF MCB-1513007). O.F.B. acknowledges support from the Deutsche Forschungsgemeinschaft (DFG grant BR 5238/1-1) and the Swiss National Science Foundation (SNF grant P300PA-171225). K.C. thanks the Resnick Sustainability Institute at Caltech for fellowship support. The authors are grateful to Dr. Christopher Prier for help with initial experimental design and comments on the manuscript. We also thank Dr. David Romney and Anders Knight for helpful comments and discussions. The authors declare no competing financial interest.

Attached Files

Supplemental Material - ja9b02931_si_001.pdf

Files

ja9b02931_si_001.pdf
Files (8.8 MB)
Name Size Download all
md5:e46ba59d42d03a278f0bd2b7bae6f891
8.8 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023